See Local News
Get Balanced News From Your U.S. State.
See Local News
See all locals

The science events to watch for in 2023

Posted on AllSides December 20th, 2022
From The Center
H Stockebrand/Rubin Obs/NSF/AURA
ANALYSIS

Next-generation vaccines

Following the successful deployment of mRNA vaccines during the COVID-19 pandemic, a host of them are in development. BioNTech in Mainz, Germany, is expected to initiate first-in-human trials for mRNA vaccines against malaria, tuberculosis and genital herpes in the coming weeks. BioNTech is also collaborating with Pfizer, based in New York City, to trial an mRNA-based vaccine candidate to reduce the rate of shingles. Moderna in Cambridge, Massachusetts, also has mRNA vaccine candidates for the viruses that cause genital herpes and shingles.

In November, BioNTech and Pfizer began their phase...

Read full story
https://www.nature.com/articles/d41586-022-04444-3

More News about Science from the Left, Center and Right

From the Left

From the Center

From the Right